Tirzepatide vs Semaglutide

Both medicines influence appetite and help the body manage glucose. Each option has a slightly different effect on hunger and metabolism, and that difference often guides a clinician’s recommendation.

How Each Medicine Works

Semaglutide focuses on one hormone pathway. Tirzepatide acts on two, which may produce stronger appetite control for some people.

Differences in Effectiveness

Studies often show greater weight reduction with tirzepatide at higher doses. Semaglutide still provides strong results and has been used longer, which gives doctors more experience with it.

These comparisons come from trials of the FDA-approved brand-name products (Zepbound®, Wegovy®). Compounded formulations of either ingredient have not been studied in clinical trials, and the FDA does not evaluate them for safety, effectiveness, or quality.

Side Effects

Both medicines can cause nausea, reduced appetite, stomach discomfort, or fatigue. Tirzepatide may cause these more quickly because of its broader activity. Doctors usually start at the lowest dose and rise slowly.